THIS IS HUGE ...SHORT INTEREST IS A RECORD 20 MILLION SHARES!!
NEW YORK, June 28 (Reuters) - Elan Corp Plc (NYSE:ELN - News) shares climbed before the bell on Monday, after the Irish drug maker and its U.S. partner Biogen Idec (NasdaqNM:BIIB - News) said that U.S. regulators had given their drug Antegren, used for the treatment of multiple sclerosis, priority review.
ADVERTISEMENT
Shares of Elan were up to $25.30 on the INET electronic brokerage from is prior close on the New York Stock Exchange of $23.97
CONGRATS TO ALL WHO FOLLOWED THIS ONE .. APPROVAL BUY NOVEMBER!
READ IT HERE www.tixx.com/elan.htm
NEW YORK, June 28 (Reuters) - Elan Corp Plc (NYSE:ELN - News) shares climbed before the bell on Monday, after the Irish drug maker and its U.S. partner Biogen Idec (NasdaqNM:BIIB - News) said that U.S. regulators had given their drug Antegren, used for the treatment of multiple sclerosis, priority review.
ADVERTISEMENT
Shares of Elan were up to $25.30 on the INET electronic brokerage from is prior close on the New York Stock Exchange of $23.97
CONGRATS TO ALL WHO FOLLOWED THIS ONE .. APPROVAL BUY NOVEMBER!
READ IT HERE www.tixx.com/elan.htm
Comment